Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells-Reference-Cited by-同舟云学术

Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells

Published:2011-12 Issue:2 Volume:311 Page:177-186
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chou Yu-Wei,Chaturvedi Nagendra K.,Ouyang Shougiang,Lin Fen-Fen,Kaushik Dharam,Wang Jue,Kim Isaac,Lin Ming-Fong

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Cancer statistics, 2008;Jemal;CA. Cancer J. Clin.,2008

2. The role of histone deacetylases in prostate cancer;Abbas;Epigenetics,2008

3. Gene silencing in cancer in association with promoter hypermethylation;Herman;N. Engl. J. Med.,2003

4. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer;Minucci;Nat. Rev. Cancer,2006

5. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells;Waltregny;Eur. J. Histochem.,2004

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From HDAC to Voltage-Gated Ion Channels: What’s Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer;Cancers;2022-09-10

2. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics;Anti-Cancer Agents in Medicinal Chemistry;2022-09

3. From Therapy Resistance to Targeted Therapies in Prostate Cancer;Frontiers in Oncology;2022-05-24

4. Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells;Biomolecules;2022-01-23

5. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs;International Journal of Molecular Sciences;2021-07-10